Fifty-nine neonates (age < 30 days) with TGA, hypoplastic left heart syndrome (HLHS) or aortic arch anomalies received 3 intravenous doses of EPO (500 or 1,000 U/kg) or placebo before and after hypothermic CPB. This evidence concerns the gene EPO and transposition of the great arteries.